BNTX
Biontech Se
$108.23
Earnings Summary
Revenue | $1244.8Mn |
Net Profits | $198.1Mn |
Net Profit Margins | 15.91% |
Highlights
Biontech Se’s revenue fell -15.84% since last year same period to $1244.8Mn in the Q3 2024. On a quarterly growth basis, Biontech Se has generated 867.21% jump in its revenue since last 3-months.
Biontech Se’s net profit fell -56.74% since last year same period to $198.1Mn in the Q3 2024. On a quarterly growth basis, Biontech Se has generated 124.52% jump in its net profits since last 3-months.
Biontech Se’s net profit margin fell -48.6% since last year same period to 15.91% in the Q3 2024. On a quarterly growth basis, Biontech Se has generated 102.54% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Biontech Se post its latest quarter earnings
EPS Estimate Current Quarter | -1.7 |
EPS Estimate Current Year | -1.7 |
Highlights
Biontech Se’s earning per share (EPS) estimates for the current quarter stand at -1.7 - a 15.84% jump from last quarter’s estimates.
Biontech Se’s earning per share (EPS) estimates for the current year stand at -1.7.
Key Ratios
Key ratios of the Biontech Se post its Q3 2024 earnings
Earning Per Share (EPS) | 0.88 |
Highlights
Biontech Se’s earning per share (EPS) jumped 31.34% since last year same period to 0.88 in the Q3 2024. This indicates that the Biontech Se has generated 31.34% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-11-04 | -1.7 | 0.88 | 151.76% |
2024-05-06 | -1.17 | -1.41 | -20.51% |
2024-08-05 | -2.02 | -3.36 | -66.34% |
₹0 US Stocks a/c Opening Fee